Shimadzu Corp.

Shimadzu Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw its stock decline significantly on October 29, 2025. Despite a challenging trading session, the company maintains strong management efficiency with a return on equity of 10.69% and a low debt profile, although its stock valuation remains elevated.

Shimadzu Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw its stock rise significantly on October 22, 2025. Despite recent gains, the company has struggled over the past year, with a notable decline, contrasting with the broader market's performance. Its market capitalization stands at JPY 1,075,623 million.

Shimadzu Corp. saw a significant decline in its stock price on October 14, 2025, contrasting with the Japan Nikkei 225's performance. Over the past week and year, the company has struggled, underperforming the index. Despite this, Shimadzu exhibits strong management efficiency and low debt levels, though its valuation remains high.

Shimadzu Corp., a key player in the Pharmaceuticals & Biotechnology sector, saw a notable rise on October 6, 2025, outperforming the Japan Nikkei 225. Despite recent gains, the company faces longer-term challenges with a year-to-date decline. It maintains strong management efficiency and low debt levels, ensuring financial stability.